Harm reduction and control of HIV in IDUs in France-Reference-Cited by-同舟云学术

Harm reduction and control of HIV in IDUs in France

Published:2008-08 Issue:9637 Volume:372 Page:448
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Carrieri M Patrizia,Spire Bruno

Publisher

Elsevier BV

Subject

General Medicine

Reference5 articles.

1. Progress or backsliding on HIV and illicit drugs in 2008?;Csete;Lancet,2008

2. Buprenorphine use: the international experience;Carrieri;Clin Infect Dis,2006

3. Harm reduction interventions, behaviours and associated health outcomes in France, 1996–2003;Emmanuelli;Addiction,2005

4. Impact of a harm-reduction policy on HIV and hepatitis C virus transmission among drug users: recent French data—the ANRS-Coquelicot Study;Jauffret-Roustide;Subst Use Misuse,2006

5. Anon. Stratégies thérapeutiques pour les personnes dépendantes des opiacés: place des traitements de substitution. Conférence de consensus—Fédération française d'addictologie; Lyon, France; June 23–24, 2004.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling the cost‐effectiveness and impact on fatal overdose and initiation of buprenorphine–naloxone treatment at syringe service programs;Addiction;2022-04-03

2. Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?;Journal of Addictive Diseases;2015-06-15

3. Transitions from Injection-Drug-Use-Concentrated to Self-Sustaining Heterosexual HIV Epidemics: Patterns in the International Data;PLoS ONE;2012-03-01

4. Human Rights and HIV Prevention, Treatment, and Care for People Who Inject Drugs: Key Principles and Research Needs;JAIDS Journal of Acquired Immune Deficiency Syndromes;2010-12-01